The authors investigated the efficacy of CD29- and CD44-targeted NIR-PIT (CD29-PIT and CD44-PIT, respectively) in the B16 melanoma model, which was highly pigmented.
[Oncoimmunology]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.